A Kaiser Family Foundation analysis found Medicare spending on Mylan's EpiPen drastically increased between 2007 and 2014, according to Yahoo! Finance.
Here are five highlights:
1. In seven years, Medicare spending on the EpiPen increased 1,151 percent.
2. The number of EpiPen users rallied 164 percent from 2007 to 2014.
3. Medicare spent $7 million on EpiPen in 2007 for 79,980 users in 2007.
4. That figure increased to $87.9 million in 2014.
5. In 2014, nearly 211,500 Medicare members used EpiPen.
More articles on coding & billing:
3 legislative changes impacting ASCs — Sept. 21, 2016
Sen. Bernie Sanders and others leading campaign to offer public option on ACA: 5 things to know
Connecticut's Insurance Commissioner withdrawing from Anthem-Cigna review: 7 takeaways